Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients-Reference-Cited by-同舟云学术

Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients

Published:2020-06 Issue: Volume:17 Page:448-454
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Kunz Alexander,Gern Ulrike,Schmitt Anita,Neuber Brigitte,Wang Lei,Hückelhoven-Krauss Angela,Michels Birgit,Hofmann Susanne,Müller-Tidow Carsten,Dreger Peter,Schmitt Michael,Schubert Maria-Luisa

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference19 articles.

1. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia;Maude;N. Engl. J. Med.,2018

2. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults;Gardner;Blood,2017

3. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia;Park;N. Engl. J. Med.,2018

4. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci. Transl. Med.,2014

5. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia;Porter;Sci. Transl. Med.,2015

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the phenotypic and genetic spectrum of GTPBP3 deficiency: findings from nine Chinese pedigrees;2024-09-11

2. Quantification of circulating TCR-engineered T cells targeting a human endogenous retrovirus post-adoptive transfer using nanoplate digital PCR;Molecular Therapy - Methods & Clinical Development;2024-09

3. Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain;Cancer Research Communications;2024-09-01

4. Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study;Leukemia;2024-08-27

5. Finding Your CAR;The American Journal of Pathology;2024-08